Exécution de notre outil de synthèse sur un nouvel article

Vérifiez l’article ci-dessous, puis lancez sa synthèse.


Clinical Meaningfulness of Individual Items of the Brief Ataxia Rating Scale and the Scale for the Assessment and Rating of Ataxia

D. Apaydin, J. D. Schmahmann

medRxiv preprint
DOI: 10.64898/2026.09.15.26362565 (medRxiv: Neurology)
Licence : non indiquée (tous droits réservés)

Résumé : IntroductionThe Brief Ataxia Rating Scale (BARS) and Scale for the Assessment and Rating of Ataxia (SARA) are used to quantify cerebellar ataxia severity. We investigated how often clinicians ratings match patients reports of functional impairment, which scale items patients consider important, and whether incremental changes in item scores are meaningful to patients. Methods30 patients with cerebellar ataxia completed BARS, SARA, FARS Functional Staging, and an Importance of Activities of Daily Living questionnaire. We studied BARS and SARA item scores for over- or underestimation in relation to patients perception of impairment. We explored patients rankings of item importance in relation to daily function, and their perception of the likely importance of 0.5- and 1-point changes in BARS gait and speech. ResultsPatients identified gait as most important on BARS and SARA, followed by oculomotor (BARS) and stance (SARA). Heel-to-shin was least important, with highest overestimation on both scales. Total overestimated points were similar between BARS (2.65 {+/-} 2.80) and SARA (2.78 {+/-} 2.78). 0.5-point changes in BARS gait and speech scores were rated very or extremely important by 60% and 46.6%, respectively, increasing to 83.3% and 70% for a 1-point change. ConclusionGait is most meaningful to patients with cerebellar ataxia. BARS oculomotor and SARA stance rank second. BARS and SARA appendicular measures have limited patient-perceived clinical meaningfulness. 0.5-point increments in BARS gait and speech provide greater granularity of assessment and are considered meaningful by a substantial proportion of patients, supporting their relevance in practice and in clinical trials.

Publié le 21 Sep. 2026